← Back
$MLTX All transactions

MoonLake Immunotherapeutics

▼ SELL

$ Value

$1.1M

Shares

72,908

Price

$14

Filed

Dec 10

Insider

Name

Reich Kristian

Title

Chief Scientific Officer

CIK

0001920553

Roles

Officer

Transaction Details

Transaction Date

2025-12-09

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Sales made pursuant to Rule 144 under the Securities Act of 1933, as amended, to cover tax liabilities of the Reporting Person and other expenses incurred related to the sales. | The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $15.036949 to $15.101507. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. | Represents the ordinary shares of the Issuer owned by JeruCON Beratungsgesellschaft mbH. Dr. Reich directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the ordinary shares owned by JeruCON Beratungsgesellschaft mbH.

Filing Info

Accession No.

0001213900-25-120105

Form Type

4

Issuer CIK

0001821586

Reich Kristian's History

Date Ticker Type Value
2025-12-19 MLTX C
2025-12-19 MLTX D
2025-12-19 MLTX C
2025-12-09 MLTX $1.1M
2025-12-08 MLTX $2.0M
2025-09-02 MLTX C
2025-09-02 MLTX D
2025-01-20 MLTX C

Other Insiders at MLTX (90d)

Insider Bought Sold Last
BVF PARTNERS L P/IL $63.0M 2026-03-31
Santos da Silva Jorge
Chief Executive Officer
$2.8M 2026-04-13
Bodenstedt Matthias
Chief Financial Officer
$1.7M 2026-04-14